Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fry

Showing results (151-160 of 201) with videos related to

Pageof 21
Sort By:
Advances in Enzyme Regulation|January 1, 1987
Biochemical pharmacology and experimental chemotherapy studies with guanine-7-oxide, a novel purine antibioticR C Jackson, T J Boritzki, J A Besserer, et al.
The AAPS Journal|March 12, 2025
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 VariantsYun-Jong Park, Wojciech Jankowski, Nicholas C Hurst, et al.
Biochemical Pharmacology|November 14, 1997
Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitorD W Fry, J M Nelson, V Slintak, et al.
Science (New York, N.Y.)|August 19, 1994
A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseD W Fry, A J Kraker, A McMichael, et al.
Cancer Research|September 15, 2000
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injuryS R Ritland, S J Gendler, L J Burgart, et al.
Protist|May 7, 2025
Piercing the veil: A novel amoebozoan (Janelia veilia n. gen. n. sp.) reveals deep clades within Discosea through phylogenomicsRobert E Jones, Quentin Blandenier, Felicity Kleitz-Singleton, et al.
European Journal of Protistology|April 19, 2024
Molecular phylogenetic analyses support the validity of Ceratiomyxa porioides (Amoebozoa, Eumycetozoa) at species levelNicholas W Fry, Robert E Jones, Quentin Blandenier, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
2-Aminoquinazoline inhibitors of cyclin-dependent kinasesYadagiri Bathini, Inderjit Singh, Patricia J Harvey, et al.
Molecular Cancer Therapeutics|May 30, 2006
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L Bills, Alexander P Miceli, et al.
Journal of Medicinal Chemistry|January 5, 1996
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.
Pageof 21

Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
Advances in Enzyme Regulation|January 1, 1987
Biochemical pharmacology and experimental chemotherapy studies with guanine-7-oxide, a novel purine antibioticR C Jackson, T J Boritzki, J A Besserer, et al.
The AAPS Journal|March 12, 2025
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 VariantsYun-Jong Park, Wojciech Jankowski, Nicholas C Hurst, et al.
Biochemical Pharmacology|November 14, 1997
Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitorD W Fry, J M Nelson, V Slintak, et al.
Science (New York, N.Y.)|August 19, 1994
A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseD W Fry, A J Kraker, A McMichael, et al.
Cancer Research|September 15, 2000
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injuryS R Ritland, S J Gendler, L J Burgart, et al.
Protist|May 7, 2025
Piercing the veil: A novel amoebozoan (Janelia veilia n. gen. n. sp.) reveals deep clades within Discosea through phylogenomicsRobert E Jones, Quentin Blandenier, Felicity Kleitz-Singleton, et al.
European Journal of Protistology|April 19, 2024
Molecular phylogenetic analyses support the validity of Ceratiomyxa porioides (Amoebozoa, Eumycetozoa) at species levelNicholas W Fry, Robert E Jones, Quentin Blandenier, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
2-Aminoquinazoline inhibitors of cyclin-dependent kinasesYadagiri Bathini, Inderjit Singh, Patricia J Harvey, et al.
Molecular Cancer Therapeutics|May 30, 2006
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L Bills, Alexander P Miceli, et al.
Journal of Medicinal Chemistry|January 5, 1996
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.
Pageof 21